Thryvv : ratio page

Neuland Laboratories

Overview Articles News Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2024
Mar2023
Mar2022
Mar2021
Mar2020
Valuation Parameters:
PE(x)
26.86
14.12
20.64
33.22
22.43
PCE(x)
22.40
10.67
11.67
22.27
7.66
Price/Book(x)
6.29
2.32
1.57
3.41
0.51
Yield(%)
0.22
0.56
0.49
0.24
0.71
EV/Net Sales(x)
5.15
1.99
1.61
3.02
0.76
EV/Core EBITDA(x)
16.89
8.42
10.56
17.37
5.45
EV/EBIT(x)
19.32
10.36
15.97
22.96
7.74
EV/CE(x)
5.88
2.13
1.43
2.14
0.47
MCap / Sales
5.17
1.94
1.38
2.86
0.48
Growth Ratio:
Net Sales Growth(%)
30.84
25.25
1.51
22.84
14.38
Core EBITDA Growth(%)
68.73
94.61
-11.18
54.02
70.98
EBIT Growth(%)
81.56
139.20
-22.38
65.42
106.93
PAT Growth(%)
83.51
156.21
-20.85
397.40
-1.41
EPS Growth(%)
83.51
156.21
-20.85
397.40
-1.41
Financial Stability Ratios:
Total Debt/Equity(x)
0.06
0.12
0.28
0.22
0.37
Current Ratio(x)
2.15
1.73
1.60
1.49
1.44
Quick Ratio(x)
1.33
1.10
0.87
0.82
0.83
Interest Cover(x)
29.68
17.51
7.09
6.89
3.45
Total Debt/Mcap(x)
0.01
0.05
0.18
0.06
0.71
Operational & Financial Ratios:
Earnings Per Share (Rs)
233.89
127.45
49.74
62.85
12.63
CEPS(Rs)
280.42
168.59
87.97
93.78
37.02
DPS(Rs)
14.00
10.00
5.00
5.00
2.00
Book NAV/Share(Rs)
999.07
774.12
654.40
612.28
552.65
Tax Rate(%)
25.25
24.21
22.32
23.45
69.37
Margin Ratios:
Core EBITDA Margin(%)
29.68
22.82
15.00
15.67
13.36
EBIT Margin(%)
26.65
19.21
10.06
13.15
9.77
Pre Tax Margin(%)
25.76
18.11
8.64
11.24
6.94
PAT Margin (%)
19.25
13.73
6.71
8.61
2.13
Cash Profit Margin (%)
23.08
18.16
11.87
12.84
6.23
Performance Ratios:
ROA(%)
17.59
11.04
4.71
6.31
1.37
ROE(%)
26.38
17.84
7.85
10.79
2.30
ROCE(%)
33.51
20.94
9.44
12.81
7.85
Asset Turnover(x)
0.91
0.80
0.70
0.73
0.65
Sales/Fixed Asset(x)
1.54
1.28
1.09
1.22
1.18
Working Capital/Sales(x)
3.16
3.70
4.37
5.17
4.84
Efficiency Ratios:
Fixed Capital/Sales(x)
0.65
0.78
0.91
0.82
0.85
Receivable days
86.10
91.33
86.74
79.40
84.68
Inventory Days
73.73
83.41
98.40
91.00
98.63
Payable days
114.75
110.05
116.52
111.44
112.92